Vaxil  BioTherapeutics Ltd.

Vaxil BioTherapeutics Ltd. PowerPoint PPT Presentation


  • 163 Views
  • Uploaded on
  • Presentation posted in: General

2. Overview. . Vaxil has developed VaxHit, a technology to identify Vaccine Candidate (VCs) with the ability to induce specific, robust and broader T-cell immunity for different cancers and key infectious diseases. Lead product ImMucin, a MUC1 cancer vaccine is being evaluated in a Phase I/II cl

Download Presentation

Vaxil BioTherapeutics Ltd.

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


1. 1 Vaxil BioTherapeutics Ltd.

5. Vaccines for Adoptive immunity: Rational & Challenges

9. Vaxil’s technological approach: VaxHit (I)

11. Therapeutic vaccines: The essentials

12. 12 Vaxil’s approach: Comparison vs. current solutions

14. ImMucin: Potential for “Pipeline In A Product”

15. ImMucin: Potential for “Pipeline In A Product”

16. ImMucin (VXL100): Anti-MUC1 vaccine

17. ImMucin: in-vitro & ex-vivo Characterization

19. ImMucin: A first in man study

20. Thank you

  • Login